Press release
OTC Vet Meds Announced launch of Generic pet medicines for pets
Pet owners in America spent $25.45 billion on the pet supplies, over-the-counter pet medicines and in the vet care in 2010, according to survey conducted by Pet Products Association America. The yearly cost of taking care of a dog or cat in the U.S ranges between $800 and $900. With monthly tick and flea treatments costing as much as $12 to $14 per dose, there is no doubt that Pet medicines contribute for a huge portion of American pet care expenses. One can also not deny the fact that some pet medications are important part of a responsible pet ownership. Taking the cost factor and the importance of Pet medications, into consideration OTC Vet Meds has announced the launch of Generic pet medicines for pets.“We are happy to enter in to the new era of affordable, convenient generic versions of the bestselling pet medications available to consumers, now consumers will be able to purchase the generic equivalents at lower price than the brand-name products at OTC Vet Meds”, said Mr.RavindraDasarwar CEO of OTC Vet Meds.
Now for the pet owners who are tired of paying the outrageous costs on the pets like dogs and cats generic alternative medicines prove to be the best option. “If the generic variants of pet medication works as well as the real meds than, I’ll surely go for the generic version to save on money” said one of the regular customers of OTC Vet Meds, whose family includes two dogs and a cat, in addition to her husband and two children.
A result of expiring patents of branded pet drugs, more and more generic alternatives of pet meds are finding their way into the veterinarian’s offices, many of the research experts believe that generics will account for half of all pet medications within a decade.
Generic equivalents of brand-name drugs have the same active ingredients as that available in the original products. For example DA Double Advantage for Dogs from OTC Vet Meds is the generic equivalent of K9 Advantix, which contains exactly the same ingredients as used in K9 Advantix for the prevention and treatment of ticks, fleas, mosquitoes, biting flies and lice on dogs and it costs almost half the rate of its original counterpart.
The clinical researchers reported saying that, generics have no proven side effects that are different from brand-names and are safe on the pets. However no drug in the market is allowed to sell unless the product meets necessary stringent safety, efficacy and manufacturing standards. If you see the facts, an estimated 50 percent of the generic drug production is by brand-name firms or their subsidiaries.
Visit us at:- http://www.otcvetmeds.com
Buy here:- http://www.otcvetmeds.com/da-double-advantage.html
Join Us:- http://blog.otcvetmeds.com
OTC Pet Meds
10685-B Hazelhurst Dr. # 11132
Houston, TX 77043
USA
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release OTC Vet Meds Announced launch of Generic pet medicines for pets here
News-ID: 188762 • Views: …
More Releases for OTC
Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact…
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain adidas AG officers and…
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE
Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services.
The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology…
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,…
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
The…
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF).
Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…